Blog

Cancer Immunotherapy May Be Safe for Rheumatology Patients – Medscape


Medscape

Cancer Immunotherapy May Be Safe for Rheumatology Patients
Medscape
Powerful cancer immunotherapy may be safe for some patients with underlying rheumatologic disease, a small study indicates. Uma Thanarajasingam, MD, PhD, from the Mayo Clinic in Rochester, Minnesota, and colleagues, published their findings online

2018-01-29 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.